"CLINICAL TRIALS available to our community."

During the past decade, Optimus U Corporation conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 10 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 10 clinical trials were completed. i.e. 43.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Optimus U Corporation" #1 sponsor was "Pfizer" with 6 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Optimus U Corporation" #1 collaborator was "H. Lundbeck A/S" with 3 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "Pharmaceutical Product Development, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Optimus U Corporation" are "Alzheimer Disease" (8 trials), "Bipolar I Disorder" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Alzheimer's Disease" (2 trials) and "Depressive Disorder, Major" (2 trials). Many other conditions were trialed in "Optimus U Corporation" in a lesser frequency.

Most popular intervention types in "Optimus U Corporation" are "Drug" (30 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Brexpiprazole" (3 trials), "Donanemab" (3 trials), "Gantenerumab" (3 trials) and "AVP-786" (2 trials). Other intervention names were less common.

The vast majority of trials in "Optimus U Corporation" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Optimus U Corporation". undefined are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Optimus U Corporation, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Optimus U Corporation, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".